$38.00
-10.75[-22.05%]
At close: Apr 26
$38.00
0[0.00%]
After Hours: 8:29AM EDT
Belite Bio
(NASDAQ:BLTE)Belite Bio Stock (NASDAQ:BLTE), Quotes and News Summary
Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
| Open | $48.930 |
| Close | $48.950 |
| Volume / Avg. | 19.495K / 42.014K |
| Day Range | 47.670 - 48.950 |
| 52 Wk Range | 11.000 - 49.160 |
| Market Cap | $1.132B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 77 |
| Short Interest | 0.3% |
| Days to Cover | 1.16 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Belite Bio (BLTE) stock?
You can purchase shares of Belite Bio (NASDAQ: BLTE) through any online brokerage.
Who are Belite Bio's (BLTE) competitors?
Other companies in Belite Bio’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
What is the target price for Belite Bio (BLTE) stock?
The latest price target for Belite Bio (NASDAQ: BLTE) was reported by Benchmark on Thursday, May 16, 2024. The analyst firm set a price target for 57.00 expecting BLTE to rise to within 12 months (a possible 50.00% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Belite Bio (BLTE)?
The stock price for Belite Bio (NASDAQ: BLTE) is $38 last updated April 26, 2024 at 8:29 AM EDT.
Does Belite Bio (BLTE) pay a dividend?
There are no upcoming dividends for Belite Bio.
When is Belite Bio (NASDAQ:BLTE) reporting earnings?
Belite Bio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Belite Bio (BLTE) going to split?
There is no upcoming split for Belite Bio.
What sector and industry does Belite Bio (BLTE) operate in?
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.